Evidence map›Paper›PMID 39802056›Full record

ArticleEuropean heart journal. Case reports2025

Case report: interventional thrombectomy with haemodynamic support by veno-arterial extracorporeal membrane oxygenation as a rescue strategy in acute pulmonary embolism refractory to systemic thrombolysis.

Fuad Mahmudlu, Bassel Alahmad, Abderrahmen Mimoune, Eberhard Schulz

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fuad MahmudluDepartment of Cardiology, General Hospital Celle, Siemensplatz 4, Celle 29223, Germany.ORCID https://orcid.org/0009-0006-6371-3325
Bassel AlahmadDepartment of Cardiology, General Hospital Celle, Siemensplatz 4, Celle 29223, Germany.
Abderrahmen MimouneDepartment of Cardiology, General Hospital Celle, Siemensplatz 4, Celle 29223, Germany.
Eberhard SchulzDepartment of Cardiology, General Hospital Celle, Siemensplatz 4, Celle 29223, Germany.ORCID https://orcid.org/0000-0003-2031-6662

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High-risk pulmonary embolism (PE) is associated with significant mortality. Thrombolysis is the therapy of choice, while interventional thrombectomy may be a helpful strategy in case of contraindications or failed thrombolysis. However, the procedure may be complicated by catheter-induced embolization of clots and/or haemodynamic compromise. Case summary: We present a 32-year-old patient woman with fulminant pulmonary artery embolism. Despite immediate systemic thrombolysis, the patient remained in cardiogenic shock with rising lactate levels. Furthermore, floating clots were observed in the right atrium of the patient. As a rescue strategy, we performed interventional thrombectomy by using the Inari FlowTriever system supported by periinterventional veno-arterial extracorporeal membrane oxygenation (VA-ECMO) implantation. After a successful thrombectomy, the patient recovered and showed immediate haemodynamic improvement. Discussion: Interventional thrombectomy may be considered in patients with high-risk PE and failed thrombolytic therapy. Support by a VA-ECMO should be considered in order to prevent transient haemodynamic instability associated with accidental, catheter-induced clot mobilization from the vena cava or right atrium.

Indexed as

Case reportFailed thrombolytic therapyHigh-risk PEInari FlowTriever systemInterventional thrombectomyVA-ECMO support

Identifiers

PMID39802056
PMCPMC11718386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.